Revolution Medicines Stock Quote RVMD - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

47.94

Bid

47.16

Ask

48.49

Volume

1,846,075

46.05 Day's Range 48.10

15.4401 52 Week Range 48.61

Market Cap

7.612B

Previous Close

46.14

Open

46.21

Last Trade

48.5

Last Trade Time

Financial Volume

$ 87,162,245

VWAP

47.2149

Average Volume (3m)

1,532,929

Shares Outstanding

164,986,227

Dividend Yield

PE Ratio

-0.08

Earnings Per Share (EPS)

-2.64

Revenue

11.58M

Net Profit

-436.37M

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.revmed.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Revolution Medicines Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RVMD. The last closing price for Revolution Medicines was $46.14. Over the last year, Revolution Medicines shares have traded in a share price range of $ 15.4401 to $ 48.61.

Revolution Medicines currently has 164,986,227 shares outstanding. The market capitalization of Revolution Medicines is $7.61 billion. Revolution Medicines has a price to earnings ratio (PE ratio) of -0.08.

Form 8-K - Current report

Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer

Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.49	1.03266596417	47.45	48.61	42.61	3096103	46.22114665	CS
4	9.51	24.7462919594	38.43	48.61	36.5	2161808	43.03785944	CS
12	11.74	32.4309392265	36.2	48.61	36.11	1532929	40.74131013	CS
26	20.94	77.5555555556	27	48.61	26.56	1473296	36.05673428	CS
52	21.24	79.5505617978	26.7	48.61	15.4401	1706804	30.38889527	CS
156	17.64	58.2178217822	30.3	48.61	14.08	1118816	27.00514713	CS
260	18.59	63.339011925	29.35	56.18	14.08	908159	28.45969085	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	157.94M
CMAXCareMax Inc	$ 5.19 (228.48%)	102.61M
NUKKNukkleus Inc	$ 0.499 (55.94%)	26.19M
SNOASonoma Pharmaceuticals Inc	$ 0.423 (37.34%)	4.87M
ONDSOndas Holdings Inc	$ 1.1297 (34.06%)	2.19M
LGCBLinkage Global Inc	$ 3.6601 (-29.82%)	168k
CGBSCrown LNG Holdings Ltd	$ 0.9997 (-29.10%)	3.38M
SPECSpectaire Holdings Inc	$ 0.3962 (-24.53%)	1.87M
GSUNGolden Sun Health Technology Group Ltd	$ 5.13 (-23.66%)	158.58k
PSNLPersonalis Inc	$ 2.9808 (-22.58%)	3.1M
NVDANVIDIA Corporation	$ 123.54 (4.76%)	238.8M
SQQQProShares UltraPro Short QQQ	$ 8.09 (-4.37%)	183.24M
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	157.94M
SERVServe Robotics Inc	$ 8.73 (15.63%)	151.44M
NCPLNetcapital Inc	$ 0.1118 (7.50%)	124.21M